{"organizations": [], "uuid": "69b01b97bd30be9bdaf415c220f4fc05c40c9560", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180502.html", "section_title": "Archive News &amp; Video for Wednesday, 02 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-novo-nordisk-beats-q1-expectations/brief-novo-nordisk-beats-q1-expectations-lifts-2018-guidance-a-tad-idUSASO00043U", "country": "US", "domain_rank": 408, "title": "BRIEF-Novo Nordisk Beats Q1 Expectations; Lifts 2018 Guidance A Tad", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T13:43:00.000+03:00", "replies_count": 0, "uuid": "69b01b97bd30be9bdaf415c220f4fc05c40c9560"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novo-nordisk-beats-q1-expectations/brief-novo-nordisk-beats-q1-expectations-lifts-2018-guidance-a-tad-idUSASO00043U", "ord_in_thread": 0, "title": "BRIEF-Novo Nordisk Beats Q1 Expectations; Lifts 2018 Guidance A Tad", "locations": [], "entities": {"persons": [{"name": "furthe", "sentiment": "none"}], "locations": [{"name": "saxenda", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-novo nordisk", "sentiment": "negative"}, {"name": "novo nordisk", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2 (Reuters) - NOVO NORDISK A/S SAYS:\n* OPERATING PROFIT DECREASED BY 8% IN DANISH KRONER AND INCREASED BY 6% IN LOCAL CURRENCIES IN THE FIRST THREE MONTHS OF 2018\n* 2018 OPERATING PROFIT GROWTH IS NOW EXPECTED TO BE 2-5% COMPARED WITH PRIOR GUIDANCE OF 1-5%\n* Q1 EBIT 12.4 BILLION DKK VERSUS 11.8 BILLION DKK SEEN IN REUTERS POLL\n* Q1 SALES 26.9 BILLION DKK VERSUS 26.7 BILLION DKK SEEN IN REUTERS POLL\n* 2018 SALES GROWTH IS NOW EXPECTED TO BE 3-5% MEASURED IN LOCAL CURRENCIES COMPARED WITH PRIOR GUIDANCE OF 2-5%\n* Q1 NET PROFIT 10.8 BILLION DKK VERSUS 10.1 BILLION DKK SEEN IN REUTERS POLL\n* 2018 SALES GROWTH AND OPERATING PROFIT GROWTH REPORTED IN DANISH KRONER ARE NOW EXPECTED TO BE 6 AND 9 PERCENTAGE POINTS LOWER THAN IN LOCAL CURRENCIES, RESPECTIVELY\n* CEO SAYS “BASED ON PERFORMANCE OF OUR KEY PRODUCTS VICTOZA, TRESIBA AND SAXENDA, WE DELIVERED SOLID UNDERLYING GROWTH IN BOTH SALES AND OPERATING PROFIT IN FIRST THREE MONTHS OF 2018”\n* EXPECTS SALES IN 2019 TO BE NEGATIVELY IMPACTED BY 1-2% AS A RESULT OF NEW REQUIREMENTS FOR MEDICARE PART D COVERAGE SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-02T13:43:00.000+03:00", "crawled": "2018-05-03T12:17:03.008+03:00", "highlightTitle": ""}